A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom MacroglobulinemiaWanlu Ma1, JiaWei Zhao2, Lu Zhang31Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China
2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China
Keywords: Waldenstrom macroglobulinemia, Rituximabinduced thrombocytopenia, Ixazomib
Waldenström Makroglobulinemisinde Rituksimab İçermeyen Yeni Umut Verici Oral Iksazomib TedavisiWanlu Ma1, JiaWei Zhao2, Lu Zhang31Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Endocrinology, Beijing, China
2Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Rheumatology, Beijing, China
3Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Department of Hematology, Beijing, China
Anahtar Kelimeler: Waldenström makroglobülinemisi, Rituksimab ile indüklenen trombositopeni, Iksazomib
Wanlu Ma, JiaWei Zhao, Lu Zhang. A Promising New Therapy of Oral Ixazomib Without Rituximab for Waldenstrom Macroglobulinemia. Turk J Hematol. 2021; 38(1): 87-89
Corresponding Author: Lu Zhang, China |
|